Back to search

Article

Serological assessment of PRO-C16 (type XVI collagen formation) reflects intestinal fibrostenotic strictures in patients with Crohn’s disease

2025-02-03

Abstract excerpt

<title>Abstract</title> <p>Background Fibrostenotic stricturing disease affects 30–50% of patients with Crohn’s disease (CD) leading to intestinal resection. Currently, there exists a great medical need to identify biomarkers related to fibrostenotic strictures for optimized patient management. Thus, we investigated PRO-C16 as a biomarker for intestinal fibrosis in patients with CD. Methods Human serum from two...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d443b2e-ecf9-53f9-b49d-d0de8f12393f
DOI
10.21203/rs.3.rs-5882259/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serological assessment of PRO-C16 (type XVI collagen formation) reflects intestinal fibrostenotic strictures in patients with Crohn’s diseaseDOI 10.21203/rs.3.rs-5882259/v1
Select a neighboring publication to make it the new centre.